When precursor frequencies were evaluated, it was determined that a much lower number of CML-specific CD8 T cells (1:38,000) was observed in comparison to CD4 cells (1:4,000). The gene discussed is CD8A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.